Preliminary core sets for endpoints in ankylosing spondylitis

Journal of Rheumatology

Volumn 24, Issue 11, 1997, Pages 2225-2229

  Van Der Heijde, Désirée ^a,f   Bellamy, Nicholas ^b   Calin, Andrei ^c   Dougados, Maxime ^d   Khan, Muhammad Asim ^e   Van Der Linden, Sjef ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c Royal National Hospital   (United Kingdom)

^d Hôpital Cochin ^*  (France)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ankylosing spondylitis; Endpoints; Methodology; Outcome

Indexed keywords

ANTIRHEUMATIC AGENT;

ANKYLOSING SPONDYLITIS; ARTICLE; METHODOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; MOVEMENT; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PHYSICAL THERAPY MODALITIES; SPINE; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 0030697069     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fries JF, Spitz PW, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthriris Rheum 1980;23:137-45.
2. Kirwan J: A theoretical framework for process, outcome and prognosis in rheumatoid arthritis. J Rheumatol 1992;19:333-6.
3. Conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials, Maastricht, The Netherlands, April 29-May 3, 1992. J Rheumatol 1993;20:525-91.
4. Tugwell P, Boers M: OMERACT Conference on Outcome Measures in Rheumatoid Clinical Trials: Introduction. J Rheumatol 1993;20:528-30.
5. Creemers MCW, van't Hof MA, Franssen MJAM, van de Putte LBA, Gribnau FWJ, van Riel PLCM: Disease activity in ankylosing spondylitis: Selection of a core set of variables and a first step in the development of a disease activity score. Br J Rheumatol 1996;35:867-73.
6. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A: A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
7. Jones SD, Steiner A, Garrett SL, Calin A: The Bath Ankylosing Spondylitis Global Score (BAS-G). Br J Rheumatol 1996;35:66-71.
8. Tugwell P, Boers M, for the OMERACT Committee: Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. J Rheumatol 1993;20:555-6.
9. Edmonds JP, Scott DL, Furst DE, Brooks P, Paulus HE: Antirheumatic drugs: A proposed new classification. Arthritis Rheum 1993;36:336-9.
10. Boers M: Validity of radiography as outcome measure in rheumatoid arthritis. J Rheumatol 1995;22:1783-6.
11. Calin A, Garrett S, Whitelock H, O'Hea J, Mallorie P, Jenkinson T: New approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
12. Dougados M, Gueguen A, Nakache J-P, Nguyen M, Mery C, Amor B: Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988;15:302-7.
13. Bakker C, Boers M, van der Linden S: Measures to assess ankylosing spondylitis: Taxonomy, review and recommendations. J Rheumatol 1993;20:1724-30.
14. Mander M, Simpson JM, McLellan A, et al: Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 1987;46:197-202.
15. Delbecq Al, van de Ven Ah, Gustafson DH: Group Techniques for Program Planning - A Guide to Nominal Group and Delphi Processes. Glenview, CA: Scott, Foresman, 1975.
16. Gustafson D, Rose J, Fryback D: The Integrative Group Process -A Severity Index Development Methodology. Madison, WI: University of Wisconsin Center for Health Systems Research and Analysis (undated).
17. Fried BJ, Boers M, Baker PRA: A method for achieving consensus on rheumatoid arthritis outcome measures: The OMERACT conference process. J Rheumatol 1993;20:548-51.